Abbie Ba-Mancini

Statistics

Publications

Citations

166

H-Index

Active since

2013

Affiliations

Millennium Engineering and Integration (United States)(Current)

Takeda (United States)

Abbie Ba-Mancini is an author at Millennium Engineering and Integration (United States) specializing in multiple myeloma therapy, multiple myeloma, and multiple myeloma treatment.

Publications per year

2013–2019

Publications

Health Care Costs and Resource Utilization, Including Patient Burden, Associated With Novel-Agent-Based Treatment Versus Other Therapies for Multiple Myeloma: Findings Using Real-World Claims Data

April Teitelbaum, Abbie Ba-Mancini, Hui Huang et al. · The Oncologist · 2013 · 67 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +16

The Cost-Effectiveness of Initial Treatment of Multiple Myeloma in the U.S. With Bortezomib Plus Melphalan and Prednisone Versus Thalidomide Plus Melphalan and Prednisone or Lenalidomide Plus Melphalan and Prednisone With Continuous Lenalidomide Maintenance Treatment

Louis P. Garrison, Si-Tien Wang, Hui Huang et al. · The Oncologist · 2013 · 60 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +14

Efficacy and Safety Of Three Bortezomib-Based Induction and Maintenance Regimens In Previously Untreated, Transplant-Ineligible Multiple Myeloma (MM) Patients (Pts): Final Results From The Randomized, Phase 3b, US Community-Based UPFRONT Study (NCT00507416)

Rubén Niesvizky, Ian W. Flinn, Robert M. Rifkin et al. · Blood · 2013 · 20 citations

Medicine, Hematology, Pharmacotherapy +16

Cost Offsets in the Treatment Journeys of Patients With Relapsed/Refractory Multiple Myeloma

Sikander Ailawadhi, Maral DerSarkissian, Mei Sheng Duh et al. · Clinical Therapeutics · 2019 · 19 citations

Pharmacy, Oncology, Pharmacoeconomics +16

1–4 of 4